J
Jacques Ferlay
Researcher at International Agency for Research on Cancer
Publications - 145
Citations - 276378
Jacques Ferlay is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 69, co-authored 129 publications receiving 211074 citations.
Papers
More filters
Journal ArticleDOI
International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification
TL;DR: Uveal melanoma incidence rates in the United States SEER Caucasian population is due mainly to an incidence decline in the early registration period (from 1974-76 to 1986-88), and the data from France and Italy suggest a recent increase in incidence.
Journal ArticleDOI
Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden.
Gholamreza Roshandel,Jacques Ferlay,Ali Ghanbari-Motlagh,Elham Partovipour,Fereshteh Salavati,Kimia Aryan,Gohar Mohammadi,Mostafa Khoshaabi,Alireza Sadjadi,Masoud Davanlou,Fereshteh Asgari,Hakimeh Abadi,Abbas Aghaei,Seyed-Vahid Ahmadi-Tabatabaei,Kazem Alizadeh-Barzian,Abbasali Asgari,Noorali Asgari,Soheyla Azami,Maria Cheraghi,Floria Enferadi,Masoumeh Eslami-Nasab,Jila Fakhery,Mohsen Farmahini Farahani,Solmaz Farrokhzad,Mansooreh Fateh,Ali Ghasemi,Fatemeh Ghasemi-Kebria,Hajar Gholami,Arash Golpazir,Susan Hasanpour-Heidari,Narjes Hazar,Hosein Hoseini-hoshyar,Mohsen Izadi,Mahdi Jahantigh,Ahmad Jalilvand,Seyed-Mehrdad Jazayeri,Yasan Kazemzadeh,Maryam Khajavi,Maryam Khalednejad,Marziyeh Khanloghi,Maryam Kooshki,Amineh Madani,Mahdi Mirheidari,Hosein Mohammadifar,Zeinab Moinfar,Yasaman Mojtahedzadeh,Ali Morsali,Rita Motidost-komleh,Tahereh Mousavi,Maboobeh Narooei,Mohammad Nasiri,Sharareh Niksiar,Mehdi Pabaghi,Habibollah Pirnejad,Azadeh Pournajaf,Gita Pourshahi,Amir Rahnama,Bahman Rashidpoor,Zahra Ravankhah,Khadijeh Rezaei,Abbas Rezaianzadeh,Gholamreza Sadeghi,Mohammad Salehifar,Athareh Shahdadi,Mehraban Shahi,Farrokh Sharifi-Moghaddam,Roya Sherafati,Ali Soleimani,Maryam Soltany-hojatabad,Mohammad-Hossein Somi,Sohrab Yadolahi,Majid Yaghoubi-ashrafi,Aliakbar Zareiyan,Hossein Poustchi,Kazem Zendehdel,Afshin Ostovar,Ghasem Janbabaei,Alireza Raeisi,Elisabete Weiderpass,Reza Malekzadeh,Freddie Bray +80 more
TL;DR: In this paper, the authors developed a method for approximating population-based incidence from the pathology-based data series available nationally for the years 2008 to 2013, and augmented this with data from the Iranian National Population-based Cancer Registry (INPCR), and fitted timelinear age-period models to the recent incidence trends to quantify the future cancer incidence burden to the year 2025, delineating the contribution of changes due to risk and those due to demographic change.
Journal ArticleDOI
Global demand for cancer surgery and an estimate of the optimal surgical and anaesthesia workforce between 2018 and 2040: a population-based modelling study
Sathira Perera,Susannah Jacob,Brooke E Wilson,Brooke E Wilson,Jacques Ferlay,Freddie Bray,Richard Sullivan,Michael Barton +7 more
TL;DR: In this article, the authors estimated the global demand for cancer surgery and the requirements for an optimal surgical and anaesthesia workforce, using benchmarks based on clinical guidelines, using GLOBOCAN 2018 data and then aggregated to obtain the estimated number of surgical procedures required globally.
Journal ArticleDOI
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study
Citadel J Cabasag,John Butler,Melina Arnold,Mark J. Rutherford,Mark J. Rutherford,Aude Bardot,Jacques Ferlay,Eileen Morgan,Eileen Morgan,Bjørn Møller,Anna Gavin,Charles H Norell,Samantha Harrison,Nathalie Saint-Jacques,Michael Eden,Brian Rous,Andy Nordin,Louise Hanna,Janice S. Kwon,Paul A. Cohen,Alon D. Altman,Lorraine Shack,Serena Kozie,Gerda Engholm,Prithwish De,Peter Sykes,Geoff Porter,Sarah E. Ferguson,Paul M. Walsh,Richard Trevithick,Hanna E. Tervonen,Dianne L. O'Connell,Freddie Bray,Isabelle Soerjomataram +33 more
TL;DR: International variations in ovarian cancer survival by stage exist with the largest differences observed in the oldest age group with advanced disease, and this finding endorses further research investigating international differences in access to and quality of treatment, and prevalence of comorbid conditions particularly in older women withAdvanced disease.
Journal ArticleDOI
The recent decline in mortality from Hodgkin lymphomas in central and eastern Europe
Cristina Bosetti,Fabio Levi,Jacques Ferlay,F. Lucchini,Eva Negri,C. La Vecchia,C. La Vecchia +6 more
TL;DR: The present work confirms the persistent declines in HL mortality in western European countries, and shows favorable patterns over more recent calendar years in central/eastern ones, where rates are still at levels observed in western Europe in the early 1990s.